Is BDNF‐Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population‐based cohort study

2018 ◽  
Vol 180 (2) ◽  
pp. 113-121
Author(s):  
Umut Kirli ◽  
Tolga Binbay ◽  
Marjan Drukker ◽  
Hayriye Elbi ◽  
Bülent Kayahan ◽  
...  
2020 ◽  
Vol 177 (4) ◽  
pp. 308-317 ◽  
Author(s):  
Sarah A. Sullivan ◽  
Daphne Kounali ◽  
Mary Cannon ◽  
Anthony S. David ◽  
Paul C. Fletcher ◽  
...  

2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S65-S66 ◽  
Author(s):  
Wing Chung Chang ◽  
Joe Kwun Nam Chan ◽  
Corine Sau Man Wong ◽  
Philip Chi Fai Or ◽  
JoJo Siu Han Hai

Abstract Background Ischemic heart disease is the leading cause of premature mortality in psychotic disorders. The authors aimed to examine short-term mortality, cardiovascular complications, revascularization and cardioprotective medication receipt after incident acute coronary syndrome (ACS) among patients with psychotic disorders compared with patients without psychotic disorders. Methods This was a population-based cohort study with data retrieved from a territory-wide medical record database of public healthcare services to 7.5 million residents in Hong Kong. The study identified 67,692 patients aged ≥18 years admitted for first-recorded ACS between January 1, 2006 and December 31, 2016. The cohort was dichotomously divided by pre-ACS diagnosis of psychotic disorder. Multivariate regression (adjusted odds ratio [aOR] and 95%CI) was used to examine associations of psychotic disorders with all-cause 30-day and 1-year mortality, cardiovascular complications, 30-day and 1-year invasive cardiac procedures, and 90-day post-discharge cardioprotective medication prescription. Results Patients with psychotic disorders (N=703) had higher 30-day (aOR=1.99, 95%CI=1.65–2.39) and 1-year (aOR=2.13, 95%CI=1.79–2.54) mortality, and cardiovascular complication rates (aOR=1.20, 95%CI=1.02–1.41), lower receipt of cardiac catheterization (30-day: aOR=0.54, 95%CI=0.43–0.68; 1-year: aOR=0.46, 95%CI=0.38–0.56), percutaneous coronary intervention (30-day: aOR=0.55, 95%CI=0.44–0.70; 1-year: aOR=0.52, 95%CI=0.42–0.63) and reduced β-blockers (aOR=0.81, 95%CI=0.68–0.97), statins (aOR=0.54, 95%CI=0.44–0.66), and clopidogrel prescriptions (aOR=0.66, 95%CI=0.55–0.80). Effect of psychotic disorder on heightened mortality was more pronounced in younger-aged (<65 years) and male patients. Associations between psychotic disorder and increased mortality remained significant even after complications and treatment receipt were additionally adjusted. Discussion Psychotic disorders are associated with increased risks of short-term post-ACS mortality, cardiovascular complications and inferior treatment. Excess mortality is not substantially explained by treatment inequality. Further investigation is warranted to clarify factors for suboptimal cardiac-care and elevated mortality in psychotic disorders to enhance post-ACS outcome.


2019 ◽  
Vol 60 (11) ◽  
pp. 1164-1173 ◽  
Author(s):  
Colm Healy ◽  
Helen Coughlan ◽  
James Williams ◽  
Mary Clarke ◽  
Ian Kelleher ◽  
...  

Author(s):  
Lisa R. Steenkamp ◽  
Koen Bolhuis ◽  
Laura M. E. Blanken ◽  
Maartje P. C. M. Luijk ◽  
Manon H. J. Hillegers ◽  
...  

2012 ◽  
Vol 42 (11) ◽  
pp. 2239-2253 ◽  
Author(s):  
N. Kaymaz ◽  
M. Drukker ◽  
R. Lieb ◽  
H.-U. Wittchen ◽  
N. Werbeloff ◽  
...  

BackgroundThe base rate of transition from subthreshold psychotic experiences (the exposure) to clinical psychotic disorder (the outcome) in unselected, representative and non-help-seeking population-based samples is unknown.MethodA systematic review and meta-analysis was conducted of representative, longitudinal population-based cohorts with baseline assessment of subthreshold psychotic experiences and follow-up assessment of psychotic and non-psychotic clinical outcomes.ResultsSix cohorts were identified with a 3–24-year follow-up of baseline subthreshold self-reported psychotic experiences. The yearly risk of conversion to a clinical psychotic outcome in exposed individuals (0.56%) was 3.5 times higher than for individuals without psychotic experiences (0.16%) and there was meta-analytic evidence of dose–response with severity/persistence of psychotic experiences. Individual studies also suggest a role for motivational impairment and social dysfunction. The evidence for conversion to non-psychotic outcome was weaker, although findings were similar in direction.ConclusionsSubthreshold self-reported psychotic experiences in epidemiological non-help-seeking samples index psychometric risk for psychotic disorder, with strong modifier effects of severity/persistence. These data can serve as the population reference for selected and variable samples of help-seeking individuals at ultra-high risk, for whom much higher transition rates have been indicated.


2022 ◽  
Vol 239 ◽  
pp. 123-127
Author(s):  
Kaori Endo ◽  
Syudo Yamasaki ◽  
Miharu Nakanishi ◽  
Jordan DeVylder ◽  
Satoshi Usami ◽  
...  

2013 ◽  
Vol 170 (7) ◽  
pp. 742-750 ◽  
Author(s):  
Stanley Zammit ◽  
Daphne Kounali ◽  
Mary Cannon ◽  
Anthony S. David ◽  
David Gunnell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document